Validated Spectrophotometric Method Development for Strontium Ranelate from Newly Developed Floating Tablet Formulation

Dhanashree S Chavan | Sachin A Pishawikar | Harinath N. More | Suresh G. Killedar

Abstract: In Present work, successful development of a simple, sensitive, rapid, accurate and precise spectrophotometric method has been done for the estimation of strontium ranelate in bulk and pharmaceutical dosage forms. The wavelength maxima for strontium ranelate was found to be 323 nm. Beers law was obeyed in the concentration range of 5-50 g/ml. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.2263 g/ml and 0.68 g/ml, respectively. The percentage recovery of the drug for the proposed method ranged from 96.86-104.54 % indicating no interference of the tablet excipients. The result of analysis were validated as per ICH guidelines [Q2 (R1)].

Keywords: Strontium ranelate, UV spectrophotometry, Percentage recovery, Method development, Method validation

Edition: Volume 7 Issue 1, January 2018,

Pages: 634 - 637

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait

Validated Spectrophotometric Method Development for Strontium Ranelate from Newly Developed Floating Tablet Formulation

Similar Articles with Keyword 'Method development'

Stability Indicating Method Development and Validation of the Trandolapril in Human Plasma by LCMS/MS in Bulk and Tablet Dosage Form

A QBD based RP-HPLC Method Development and Validation for Quantification of Pregabalin Capsules